Liminatus Pharma Warrants Net Tangible Assets

Liminatus Pharma Warrants posts a net tangible assets of $-17M as of March 2022. That compares with $250M in the prior-year period — down 107.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Liminatus Pharma Warrants's net tangible assets was $250M. The latest reading is $-17M — a 107.0% year-over-year decrease (period ending March 2022). Use the history and growth charts on this page for a longer lookback.

Net Tangible Assets is one piece of Liminatus Pharma Warrants's financial statement story. At $-17M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LIMNW's net tangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Liminatus Pharma Warrants's other metric pages and overview cover the third.